Sorry, you need to enable JavaScript to visit this website.
  1. Home
  2. Our Science
  3. Clinical Trials
  4. Plain Language Study Results Summaries

Plain Language Study Results Summaries

What Are Plain Language Study Results Summaries?

Plain Language Study Results Summaries are descriptions in everyday language of the design and results of clinical studies. These summaries, also called plain language summaries, simple summaries, and trial results summaries, are intended to make clinical results understandable and accessible to patients, healthcare providers, caregivers, researchers, and a general audience.

Please use the search function below to find Plain Language Study Results Summaries for Pfizer-sponsored global clinical trials.

Filter Results

Refine your search results by using the dropdown filters below. Click “reset” to return to the full list of available studies.

Klinické skúšanie na vyhodnotenie produktu PF-06730512 u dospelých osôb s fokálnou segmentálnou glomerulosklerózou (FSGS)
Category & Conditions: Infections and Infectious Diseases
Study Phase : 2
Medicine: PF-06730512
Language: Slovenian
ViewDownloadPrint
Estudio para evaluar PF-06730512 en adultos con glomeruloesclerosis segmentaria focal (GESF)
Category & Conditions: Infections and Infectious Diseases
Study Phase : 2
Medicine: PF-06730512
Language: Spanish
ViewDownloadPrint
Een studie naar PF-06755347 bij gezonde mannen
Category & Conditions: Rare Diseases
Study Phase : 1
Medicine: PF-06755347
Language: Dutch
ViewDownloadPrint
A Study of PF-06755347 in Healthy Men
Category & Conditions: Rare Diseases
Study Phase : 1
Medicine: PF-06755347
Language: English
ViewDownloadPrint
Étude portant sur le PF-06755347 chez des hommes en bonne santé.
Category & Conditions: Rare Diseases
Study Phase : 1
Medicine: PF-06755347
Language: French
ViewDownloadPrint
Eine Studie zu PF-06755347 bei gesunden Männern
Category & Conditions: Rare Diseases
Study Phase : 1
Medicine: PF-06755347
Language: German
ViewDownloadPrint
A Study to Test the Safety, Tolerability, and Immunogenicity of a Multivalent Group B Streptococcus Vaccine When Administered With Tetanus, Diphtheria, and Acellular Pertussis Vaccine (Tdap) in Healthy, Nonpregnant Women Aged 18 to 49 Years
Category & Conditions: Vaccine-related Conditions
Study Phase : 2
Medicine: PF-06760805
Language: English
ViewDownloadPrint
A Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Booster Dose of a Group B Streptococcus 6-Valent Polysaccharide Conjugate Vaccine in Healthy Adults
Category & Conditions: Vaccine-related Conditions
Study Phase : 2
Medicine: PF-06760805
Language: English
ViewDownloadPrint
Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Multivalent Group B Streptococcus Vaccine in Healthy Nonpregnant Women and Pregnant Women and Their Infants
Category & Conditions: Vaccine-related Conditions
Study Phase : 1/2
Medicine: PF-06760805
Language: English
ViewDownloadPrint
PF-06804103 Dose Escalation in HER2 Positive and Negative Solid Tumors
Category & Conditions: Cancer
Study Phase : 1
Medicine: PF-06804103
Language: English
ViewDownloadPrint
A Study to Understand the Effect of Tablet Formulation and Food on PF-06821497 in Healthy Adult Participants
Category & Conditions: Cancer
Study Phase : 1
Medicine: PF-06821497
Language: English
ViewDownloadPrint
A Study Looking at the Safety and Levels of PF-06823859 in Healthy Japanese Participants, and to see if Participants Had an Immune Response Against PF-06823859
Category & Conditions: Immune System Diseases and Conditions
Study Phase : 1
Medicine: PF-06823859
Language: English
ViewDownloadPrint